Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125378681 | 12537868 | 1 | I | 2006 | 20150625 | 20160707 | 20160707 | EXP | US-DSJP-DSU-2015-120131 | DAIICHI | 0.00 | F | Y | 77.98000 | KG | 20160707 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125378681 | 12537868 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25 MG, QD | N | 21532 | 40 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125378681 | 12537868 | 1 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125378681 | 12537868 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125378681 | 12537868 | Biliary dilatation | |
125378681 | 12537868 | Haemorrhoids | |
125378681 | 12537868 | Hepatomegaly | |
125378681 | 12537868 | Irritable bowel syndrome | |
125378681 | 12537868 | Liver disorder | |
125378681 | 12537868 | Malabsorption | |
125378681 | 12537868 | Renal failure | |
125378681 | 12537868 | Steatohepatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125378681 | 12537868 | 1 | 2005 | 2014 | 0 |